Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Loxo Oncology Inc (LOXO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Loxo Oncology Inc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Loxo Oncology Inc historical data, for real-time data please try another search
234.66 0.00    0.00%
14/02 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 234.66 - 234.88
Loxo Oncology Inc 234.66 0.00 0.00%

LOXO Recent Sentiments

 
This page contains information on users’ sentiments for the Loxo Oncology Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Feb 21, 2019 hank hsu   234.66 Mar 23, 2019 @ 234.66 0.00%
Feb 20, 2019 Kevin Coyne   234.66 Mar 22, 2019 @ 234.66 0.00%
Jan 29, 2019 fahad ibrahim   233.87 Feb 28, 2019 @ 234.66 +0.34%
Jan 10, 2019 Δημήτρης Βολικάκης   232.44 Feb 10, 2019 @ 72.14 -68.96%
Jan 07, 2019 Lakshya Mehta   232.74 Feb 07, 2019 @ 72.14 +69.00%
Jan 07, 2019 Guy Portnoy   232.86 Feb 07, 2019 @ 72.14 -69.02%
Jan 07, 2019 Róbert Török   232.88 Feb 07, 2019 @ 72.14 -69.02%
Jan 07, 2019 Juan Saldana   232.44 Feb 07, 2019 @ 72.14 -68.96%
Jan 07, 2019 Hemant Joshi   232.46 Feb 07, 2019 @ 72.14 +68.97%
Jan 07, 2019 Charles Brandon   232.40 Feb 07, 2019 @ 72.14 +68.96%
Jan 07, 2019 מישה כהן   231.65 Feb 07, 2019 @ 72.14 -68.86%
Jan 07, 2019 Иван Гансович   231.68 Jan 30, 2019 @ 234.03 -1.01%
Jan 07, 2019 Michal Palka   231.59 Feb 07, 2019 @ 72.14 -68.85%
Jan 07, 2019 Surya Kuchibhotla   231.53 Feb 07, 2019 @ 72.14 +68.84%
Jan 07, 2019 Ali Amin   231.60 Feb 07, 2019 @ 72.14 -68.85%
Jan 07, 2019 Udovin Viktor   231.84 Feb 07, 2019 @ 72.14 -68.88%
Jan 07, 2019 Dogukan ALp   232.09 Feb 07, 2019 @ 72.14 -68.92%
Jan 07, 2019 Narendra Lakhani   232.10 Jan 22, 2019 @ 233.57 -0.63%
Jan 07, 2019 Aldo Andrade   232.00 Feb 07, 2019 @ 72.14 -68.91%
Jan 07, 2019 Michal Cabarka   232.22 Feb 07, 2019 @ 72.14 +68.93%
Jan 07, 2019 William Modesti   232.36 Feb 07, 2019 @ 72.14 -68.95%
Jan 07, 2019 ???? ?????????   232.51 Feb 07, 2019 @ 72.14 -68.97%
Jan 07, 2019 Сергей Кар   232.45 Feb 07, 2019 @ 72.14 -68.97%
Jan 07, 2019 Oded Henin   232.50 Jan 07, 2019 @ 232.50 0.00%
Jan 07, 2019 Alex Chiah   232.03 Feb 07, 2019 @ 72.14 +68.91%
Jan 07, 2019 Vicente Arroyos   232.70 Feb 07, 2019 @ 72.14 -69.00%
Jan 07, 2019 Pierre Re   232.62 Jan 07, 2019 @ 0.00 0.00%
Jan 07, 2019 Justin Gramke   232.68 Feb 07, 2019 @ 72.14 -69.00%
Jan 07, 2019 Edmond Powers   233.15 Feb 07, 2019 @ 72.14 -69.06%
Jan 07, 2019 Sekar Marimuthu   232.17 Feb 07, 2019 @ 72.14 -68.93%
Jan 07, 2019 Lk Lo   232.84 Jan 29, 2019 @ 233.76 -0.40%
Jan 07, 2019 Pico Paci   231.71 Jan 21, 2019 @ 233.50 +0.77%
Jan 07, 2019 Malcom Gravel   231.75 Feb 07, 2019 @ 72.14 -68.87%
Dec 28, 2018 Tomáš Jaroš   136.85 Jan 04, 2019 @ 139.70 +2.08%
Dec 27, 2018 Tomáš Jaroš   132.55 Dec 28, 2018 @ 134.63 +1.57%
Dec 04, 2018 d andres calvo   142.95 Jan 03, 2019 @ 72.14 -49.53%
Nov 30, 2018 cp pp   139.18 Dec 30, 2018 @ 72.14 +48.17%
Nov 30, 2018 tony mo   139.44 Dec 30, 2018 @ 72.14 +48.26%
Nov 29, 2018 Göran Elmberger   141.90 Dec 29, 2018 @ 72.14 -49.16%
Nov 28, 2018 Aa Ff   140.20 Dec 28, 2018 @ 72.14 -48.54%
Nov 27, 2018 Vilem Cerny   142.02 Dec 27, 2018 @ 72.14 -49.20%
Nov 27, 2018 Michal Miko   145.04 Dec 27, 2018 @ 72.14 -50.26%
Nov 26, 2018 Ivan Dimitrov   151.19 Dec 26, 2018 @ 72.14 -52.29%
Nov 26, 2018 Mohamed Ibrahim...   152.38 Dec 26, 2018 @ 72.14 -52.66%
Nov 08, 2018 Ever Maldonado Ospino   180.18 Dec 08, 2018 @ 72.14 -59.96%
Nov 07, 2018 Erik Esparza   177.41 Dec 07, 2018 @ 72.14 -59.34%
Nov 05, 2018 Tomáš Jaroš   174.11 Dec 05, 2018 @ 72.14 -58.57%
Nov 05, 2018 primo fulvi   169.35 Dec 05, 2018 @ 72.14 -57.40%
Oct 22, 2018 Reuben Vaida   160.40 Nov 21, 2018 @ 72.14 +55.02%
Oct 05, 2018 Angel Fernandez   158.44 Nov 04, 2018 @ 72.14 -54.47%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LOXO Comments

Write your thoughts about Loxo Oncology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sekar Marimuthu
Sekar Marimuthu Jan 07, 2019 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why it's increased
Leonid Agureev
Leonid Agureev Jan 07, 2019 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lilly to buy Loxo Oncology in $8 billion cancer push
Sekar Marimuthu
Sekar Marimuthu Jan 07, 2019 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
thanks
Sekar Marimuthu
Sekar Marimuthu Jan 07, 2019 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
yes I have seen
Mi Michal
Mi Michal Nov 02, 2018 7:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They will get FDA for their drug Larotrectinib before November 26!! And the drug is amazingly efficient! Loxo will get!!!
Sekar Marimuthu
Sekar Marimuthu Nov 02, 2018 7:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good
Sekar Marimuthu
Sekar Marimuthu Nov 02, 2018 7:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ur genius
Nick LaRue
Nick LaRue Dec 19, 2017 1:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock is going to ****up this year
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email